AI Drug Discovery for Pharma and Biotech

Drug discovery

4

drugs

With orphan designations

Overview

An anal fistula is an abnormal tunnel between the anal canal and perianal skin, typically arising from cryptoglandular infections (70-90% of cases) or Crohn's disease [1][4][15]. Symptoms include pain, purulent discharge, swelling, and recurrent abscesses [1][6]. Diagnosis combines physical exam with imaging (MRI/endoscopic ultrasound) to map fistula tracts [1][3]. Surgical intervention remains cornerstone treatment, prioritizing fistula eradication while preserving sphincter integrity [1][16].

Population

  • Global prevalence: 1-2 per 10,000, peaking in males (2:1 ratio) aged 30-50 [2][7][15]

  • 12-28% cumulative incidence in Crohn's disease patients [4][17]

  • Anal fistula accounts for 52-88% of perianal fistulas in Crohn's [4][12]

Burden

  • 36-59% risk of fecal incontinence post-surgery [3][14][16]

  • 40% recurrence rate in complex cases [3][4]

  • HRQOL scores significantly reduced versus controls (SF-12 physical: 47.9 vs 54.3) [4][19]

Therapies

  • Surgical: Fistulotomy (95% success for simple cases) [5], LIFT procedure (40-95% healing) [3], advancement flaps (75-95% efficacy) [3]

  • Medical: Biologics (anti-TNFα) for Crohn's-related fistulas (49-73% response) [8][17]

  • Emerging: Stem cell therapy (53-71% remission) [4][8], FiLaC laser ablation [3][13]

Categories: rare abdominal surgical diseases, rare gastroenterological diseases

Research Papers

1,488 drug discovery papers about Anal fistula, with 1 first-in-class and 1 next-in-class emerging drug candidate forecasted to outperform the average preclinical success rate. Recent publications:

1,488 drug discovery papers about Anal fistula, with 1 first-in-class and 1 next-in-class emerging drug candidate forecasted to outperform the average preclinical success rate. Recent publications:

categories:

Small molecules

small molecules
2026-07-19 | IFTAK (Interception of Fistulous Tract with Application of Ksharasutra) Technique: A Novel Approach in the Management Anal Fistula

Fistula in ano is a chronic suppurative condition of anorectal origin that frequently develops from cryptoglandular infection and is associated with persistent symptoms, recurrence, and the potential risk of sphincter damage. Although Kshara Sutra (medicated seton) therapy is a well-established Ayurvedic surgical procedure for its management, conventional practice is often limited by prolonged treatment duration, pain, and reduced patient compliance. The Interception of Fistulous Tract with Application of Kshara Sutra (IFTAK) technique has been developed to overcome these limitations by targeting the primary site of infection. A 51-year-old male patient presented with a two-and-a-half-year history of recurrent pus discharge from the perianal region accompanied by mild pain, itching, and difficulty in sitting. Clinical examination revealed a hypertrophied external opening at 2 o’clock position and an internal opening at the 6 o’clock position at the dentate line, with normal anal sphincter tone based on clinical assessment, a diagnosis of fistula-in-ano (Bhagandara) was made. The patient was treated using the IFTAK technique under local anesthesia. Weekly Kshara Sutra changing was performed, and curettage of the tract was undertaken when indicated. Progressive improvement was noted with a marked reduction in pain and purulent discharge. Complete resolution of discharge was achieved, followed by successful cut-through and full wound healing with minimal scarring. Anal continence was preserved, and no complications were observed. The patient remained symptom-free, with no recurrence during a one-year follow-up period. This case demonstrates that the IFTAK technique is an effective and safe modification of conventional Kshara (medicated seton) Sutra therapy for fistula in ano. By addressing the primary cryptoglandular source and reducing the length of the treated tract, IFTAK offers faster healing, improved patient comfort, and favorable clinical outcomes without recurrence.

Open article ↗



2026-06-29 | Cyanoacrylate Glue Insertion Versus Seton Placement in the Management of Trans-sphincteric Anal Fistula: A Prospective Comparative Study.

Anal fistula is a common perianal condition associated with significant morbidity, recurrence, and risk of incontinence. Traditional surgical techniques such as seton placement are effective but are often associated with pain, prolonged healing time, and extended hospitalisation. Cyanoacrylate glue has emerged as a minimally invasive sphincter-preserving alternative. This prospective comparative study was conducted at Sri Ramachandra Institute of Higher Education and Research, Chennai, India, between June 1, 2023, and December 31, 2024. Fifty patients with uncomplicated trans-sphincteric fistula (St James University Hospital classification grade 3) were randomly allocated to receive either seton placement (n=25) or cyanoacrylate glue insertion (n=25). Primary outcomes included postoperative pain measured by visual analogue scale (VAS), duration of hospital stay, healing time, healing rate, and anal incontinence assessed by the Wexner continence score. The mean age was 45.3 years (SD 8.2) in the seton group and 39.1 years (SD 7.6) in the glue group. Both groups were comparable in demographic characteristics. VAS pain scores were significantly lower in the glue group compared with the seton group (mean 2.0 (SD 0.8) vs 3.4 (SD 1.1); p<0.001). Hospital stay was shorter in the glue group (2.6 days (SD 1.2) vs 5.3 days (SD 1.8); p<0.001). Healing time was significantly reduced with cyanoacrylate glue (2.75 weeks (SD 1.1) vs 5.79 weeks (SD 2.3); p<0.001). Healing rates were 96% (24 of 25) in the seton group versus 80% (20 of 25) in the glue group (p=0.189). No anal incontinence was observed in either group at three-month follow-up. Cyanoacrylate glue insertion offers a safe, minimally invasive alternative to seton placement for carefully selected patients with uncomplicated trans-sphincteric anal fistula, with significant advantages in pain reduction, shorter hospital stay, and faster healing. Although healing rates were lower with glue (80% vs 96%), this difference was not statistically significant, and the study was underpowered to detect this difference in healing rate as a secondary endpoint. All treatment failures were successfully managed with salvage fistulotomy or repeat glue application without morbidity. Larger randomised controlled trials adequately powered for healing rate as a co-primary endpoint are warranted to confirm long-term efficacy.

Open article ↗



2026-06-16 | COMPREHENSIVE CLINICAL REVIEW: MODERN AND AYURVEDIC PERSPECTIVES ON ANAL FISTULA AND FISSURE-IN-ANO

Anorectal disorders, specifically fistula-in-ano (Bhagandara) and fissure-in-ano (Parikartika), represent a significant portion of colorectal clinical practice. A fistula-in-ano is characterized by an abnormal epithelialized tract connecting the perianal skin to the anal canal, often arising from chronic anorectal abscesses. In contrast, a fissure-in-ano is a longitudinal tear in the distal anal canal mucosa. This review article explores the etiology, pathophysiology, and diagnostic frameworks for these conditions. Special emphasis is placed on the comparative analysis of modern surgical interventions—such as fistulotomy, fistulectomy, and LIFT (Ligation of Intersphincteric Fistula Tract)—against traditional Ayurvedic parasurgical procedures, specifically Kshar Sutra therapy. The objective is to provide a holistic management protocol that minimizes recurrence and preserves sphincter function. The review concludes that while modern diagnostics (MRI) are essential for mapping, the integration of Ayurvedic herbal management and Kshar Sutra offers a viable, minimally invasive alternative with low recurrence rates for complex cases.

Open article ↗



2026-06-12 | Anterior Horseshoe Anal Fistula Treated With IFTAK (Interception of Fistulous Track With Application of Ksharasutra) Technique: A Case Study.

Anterior horseshoe anal fistula is a challenging variant of complex anorectal infections. Classical surgeries, including ksharasutra therapy in these cases may result in extensive postsurgical scarring and anal incontinence. On the other hand, interception of fistulous track with application of ksharasutra (IFTAK) technique has emerged as a novel way of managing anal fistulas because of its nature of minimal invasiveness, ability to cut and heal tissues with controlled fibrosis, and continence preservation. Here, we explain a detailed case study of a 40-year-old gentleman who presented with a recurrent anterior horseshoe fistula effectively managed with IFTAK. The digital rectal examination (DRE), proctoscopy, methylene blue test, and probing were done to delineate tracts and confirm the diagnosis. Fistula healed completely and showed no recurrence at 8 months of follow-up. Compared to traditional methods, the technique results in a shorter hospital stay and a shorter treatment duration.

Open article ↗



2026-05-08 | A case report of postoperative poor drainage of perianal abscess in an obese diabetic patient treated with comprehensive therapy.

Postoperative inadequate drainage of perianal abscess is prevalent in obese patients with diabetes, caused by obesity-related high tissue pressure and diabetes-induced impaired immunity/microcirculation. We report a 25-year-old obese male (BMI 37.9 kg/m2) with newly diagnosed type 2 diabetes who developed recurrent abscess on postoperative Day 3 after surgery for perianal abscess, anal fistula, and mixed hemorrhoids. He was treated with active catheter drainage, ceftriaxone-based targeted anti-infection (guided by Klebsiella pneumoniae culture), and metformin + liraglutide for glucose control. The patient fully recovered with normalized inflammatory markers and blood glucose, without recurrence or anal fistula formation at 1-year follow-up. This validates the efficacy of the comprehensive strategy for high-risk patients with long-term clinical outcomes.

Open article ↗



antibodies
2026-09-22 | The impact of malnutrition on clinical outcomes in patients with perianal fistulizing Crohn's disease undergoing seton placement: A retrospective study.

Perianal involvement occurs in up to 50% of patients with Crohn's disease (CD). Despite combined management, 10%-20% require fecal diversion or proctectomy. Nutritional status may influence prognosis, but its role in fistulizing perianal disease is unclear. This study examines the impact of malnutrition on clinical outcomes in patients with perianal fistulizing CD. A retrospective cohort study was conducted. Clinical data were collected from the health records of patients with perianal CD at two centers from January 2010 to December 2022. Nutritional screening followed Nutrition Risk Screening-2002. Patients with a score ≥3 were evaluated for malnutrition using the Global Leadership Initiative on Malnutrition (GLIM) criteria. The prevalence of malnutrition and its association with the risk of adverse clinical outcomes were analyzed. Of 64 patients, 17 (26.6%) had malnutrition. Malnourished patients had higher proctitis rates (100% vs. 78.7%, P = 0.038), lower serum albumin (3.47 vs. 3.97 g/dL, P = 0.002), and lower hemoglobin (10.9 vs. 12.5 g/dL, P = 0.003). They were younger at diagnosis (24.2 vs. 30 years, P = 0.046), had lower body mass indices (19.7 vs. 24.9 kg/m2, P < 0.001), higher Harvey-Bradshaw index (10 vs. 5, P < 0.001), and more corticosteroid use (29.4% vs. 4.3%, P = 0.012). Malnourished patients had lower fistula healing (17.6% vs. 44.7%, P = 0.048), more proctectomies (47.1% vs. 14.9%, P = 0.007), and were more likely to undergo abdominal surgery (70.6% vs. 38.3%, P = 0.022). In the prespecified parsimonious multivariable model, malnutrition was significantly associated with proctectomy (aOR 4.478; 95% CI: 1.227-16.343; P = 0.023). Malnutrition is a significant clinical risk marker associated with the requirement for proctectomy in patients with perianal fistulizing CD who undergo seton placement.

Open article ↗



2026-09-02 | Comparison of Ligation of Intersphincteric Fistula Tract and Conventional Fistulectomy in the Management of Perianal Fistula.

Background Perianal fistula is a chronic anorectal disorder characterized by an epithelialized tract extending between the anal canal and the perianal skin, most frequently developing after cryptoglandular abscess formation. Patients commonly experience persistent discharge, pain, recurrent infections, and impaired quality of life. Although conventional fistulectomy remains an established treatment option, it may result in greater postoperative discomfort, slower wound healing, and potential impairment of continence. The ligation of intersphincteric fistula tract (LIFT) technique has gained acceptance as a sphincter-preserving procedure intended to minimize these complications while maintaining satisfactory treatment outcomes. Aim This study aimed to compare the clinical outcomes of the sphincter-preserving LIFT procedure with conventional fistulectomy in patients with perianal fistula by evaluating postoperative pain, wound infection, wound healing, postoperative fecal incontinence, and recurrence. Methods This prospective, randomized controlled trial was conducted in the Department of General Surgery at a tertiary care institution. Thirty patients with perianal fistula were randomly allocated in a 1:1 ratio to undergo either the LIFT procedure (n = 15) or conventional fistulectomy (n = 15). Outcomes assessed during follow-up included postoperative pain, wound infection, wound healing, postoperative fecal incontinence, and recurrence. Continuous variables were compared using the Mann-Whitney U test, while categorical variables were analysed using Fisher's exact test. Statistical significance was defined as a two-sided p value <0.05. Results Compared with conventional fistulectomy, the LIFT procedure was associated with significantly lower postoperative pain scores (median Visual Analogue Scale score: 2 vs. 5; Mann-Whitney U test, p < 0.001), lower rates of postoperative wound infection (6.7% vs. 46.7%; Fisher's exact test, p = 0.035), and improved postoperative wound healing (93.3% vs. 53.3%; Fisher's exact test, p = 0.035). Although postoperative recurrence (6.7% vs. 26.7%) and fecal incontinence (0.0% vs. 6.7%) occurred less frequently following the LIFT procedure, these differences were not statistically significant. Conclusion The LIFT procedure was associated with lower postoperative pain, fewer wound infections, and improved wound healing compared with conventional fistulectomy. Although lower rates of postoperative recurrence and fecal incontinence were observed following LIFT, these differences were not statistically significant. Larger multicenter studies with longer follow-up are required to confirm these findings.

Open article ↗



2026-06-30 | Association between intestinal functional disorders and anal fistula: evidence from a retrospective case-control study.

Clinical observations indicate that some individuals experience bowel dysfunction, such as diarrhea or constipation, prior to the diagnosis of anal fistula (AF). These observations suggest a potential association between pre-existing intestinal dysfunction and the occurrence of AF. However, systematic clinical evidence remains limited. This study aimed to evaluate the association between pre-diagnostic bowel dysfunction and AF and to explore whether such associations differ across AF anatomical subtypes. We conducted a retrospective hospital-based case-control study including 251 patients with newly diagnosed AF between July 2024 and July 2025. During the same period, 251 age- and sex-matched individuals without AF were selected as controls (1:1 matching; age ± 3 years). Demographic characteristics, lifestyle factors, and bowel function within 1 year before the index date were collected from medical records and supplementary interviews where applicable. Conditional logistic regression, accounting for the matched-pair design, was used to assess the association between bowel dysfunction and AF. Both crude (unadjusted) and adjusted analyses were performed. Stratified analyses were performed to explore heterogeneity across AF subtypes. Pre-existing bowel dysfunction was associated with a higher likelihood of developing AF (p < 0.05). Diarrhea showed a significant association with AF (OR ≈ 2.2), whereas constipation was not significantly associated. Smoking, alcohol consumption, prolonged sedentary or standing occupations, and higher body mass index (BMI) were also associated with AF. In exploratory analyses of AF subtypes, diarrhea showed modest heterogeneity across anatomical classifications, whereas constipation showed no significant variation across subtypes. This retrospective case-control study indicates that pre-existing intestinal functional disorders, particularly chronic diarrhea, are associated with a higher likelihood of AF, with the association appearing more pronounced among low anal fistulas. No consistent subtype-specific pattern was observed overall, although diarrhea showed modest heterogeneity across anatomical classifications in exploratory analyses. Given the retrospective observational design, these findings support association rather than causation and warrant confirmation in multicenter prospective studies. Clinically, these results suggest that earlier identification and risk assessment of patients with chronic diarrhea and other intestinal functional disturbances may provide valuable insights, but further research is needed to confirm these findings.

Open article ↗



2026-05-05 | Characteristics of Anal Fistula Cancer in Patients Who Underwent Surgery: A Nationwide Observational Study Using Diagnosis Procedure Combination Data

ABSTRACT Aim Anal fistula cancer is a rare disease that occurs in < 1% of patients with anal fistulas. The clinical characteristics of anal fistula cancer are not fully understood. This study aimed to identify the characteristics of patients with anal fistula cancer by comparing them with those of patients with anal canal or rectal cancer. Methods This was a nationwide observational study using the Diagnosis Procedure Combination data. Patients who underwent abdominoperineal resection or total pelvic exenteration for anal fistula, anal canal, or rectal cancer were included in this study. Patient background, surgical outcomes, postoperative complications, and medical costs were compared among the three types of cancer. Results This study included 206 patients with anal fistula cancer, 1207 patients with anal canal cancer, and 18 254 patients with rectal cancer. Patients with anal fistula cancer were more likely to be male, younger, or smokers. In patients with anal fistula cancer, the proportion of open surgeries was significantly higher, and the length of hospital stay was significantly longer than in those with anal canal and rectal cancer. Anal fistula cancer tended to be more locally advanced than other cancers, whereas lymph node and distant metastases were less common. The incidence of incisional wound infection and wound dehiscence was significantly higher, and medical costs were the highest in patients with anal fistula cancer. Conclusion Anal fistula cancer is characterized by aggressive local progression, resulting in a higher frequency of open surgery, a higher incidence of wound‐related complications, and higher medical costs.

Open article ↗



2025-12-30 | Anatomical Reappraisal of the Intersphincteric Space: A Histology-Based Reinterpretation of the Parks Classification of Anal Fistulas

Background: Anal fistula pathways have been traditionally described using the Parks classification; however, the microscopic nature of the “intersphincteric” space has never been characterized completely. Furthermore, the longitudinal muscle between the internal and external anal sphincters has a more complex structure than traditionally assumed. Objective: To clarify the layer-specific microanatomy of the anal sphincter region and reassess how the fistula pathways described by the Parks classification correspond to actual histological structures. Design: Descriptive histological analysis of cadaveric specimens. Settings: Department of Clinical Anatomy at Institute of Science Tokyo. Patients: Eleven adult, human donors who had consented to whole-body donation. Interventions: Tissue blocks containing the lateral anal canal were collected and processed for histological and immunohistochemical analyses in the transverse and coronal planes. Main Outcome Measures: Identification of the sphincter muscles, longitudinal muscles, levator ani muscles, interbundle gaps, and connective tissue compartments as well as their spatial relationships. Results: The longitudinal muscles exhibited a mosaic structure with dense and loose regions. The dense region ended near the mid-height of the internal sphincter, whereas the loose region expanded inferiorly to form a wide compartment of sparse fibers and loose connective tissue. From this compartment, the loose fibers branched laterally and inferiorly, passing through natural gaps within the external sphincter muscle. Two overlapping layers of the levator ani muscle were also identified. The loose compartment beneath the longitudinal muscle corresponded to the site identified by Parks classification as the origin of abscess formation. Limitations: Specimens were obtained from formalin-fixed cadavers of elderly donors, only the lateral anal canal wall was assessed, and correlations with clinical fistulas were inferential. Conclusions: The region between the sphincter muscles is not a simple plane, and instead, a heterogeneous compartment; its structural features provide a basis for the initiation and propagation patterns described in the Parks classification of anal fistulas.

Open article ↗



proteins
2025-07-09 | Single-cell RNA sequencing reveals the therapeutic mechanism of Calvatia lilacina in promoting wound healing of anal fistula

Background: Anal fistula is one of the most common and frequently occurring diseases in the anorectal department. Calvatia lilacina spore (CLS) has been applied for wound treatment with a long history as a traditional Chinese medicine (TCM). However, the mechanism of CLS to treat postoperative wound of anal fistula remains unclear. The present study aims to investigate the efficacy and mechanism of CLS in promoting anal fistula wound healing from the perspective of regulating the interaction between macrophages and fibroblasts. Methods: Twenty patients who received anal surgery were recruited in Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine. We presented a single-cell atlas of granulation tissue, comparing samples with and without CLS treatment, utilizing single-cell RNA sequencing. The pharmacological effects and mechanism of CLS on anal fistula wound were assessed using elisa, IHC staining, western blot, IF staining, flow cytometry assays and cell co-culture. Results: The CLS had a uniform particle size and contained components mainly including proteins, steroids, polysaccharides and polyphenols. CLS reduced the expression level of TNF-α and increased the expression levels of VEGF, Collagen I in the granulation tissue. The single-cell sequencing revealed that the expression level of IL-6 and CXCL-8 was increased in the IL-6+ macrophages that promoted the expression of WASF3 in fibroblasts and further recruited ACTR2, ACTR3. Finally, CLS increased intercellular communication between macrophages and fibroblasts, enhancing MSF migration ability by activating JAK2/STAT3 signaling pathway. Conclusion: Our study objectively demonstrated the pharmacological effects of CLS in promoting the wound healing of anal fistula and investigated its mechanisms in terms of regulating the immune inflammatory process of macrophages increases signal communication with fibroblasts while promoting fibroblast transformation.

Open article ↗



2025-01-15 | Curing cryptoglandular anal fistulas-Is it possible without surgery?

Empirical reviews suggested that cryptoglandular anal fistulas require surgical resolution. However, some reports have indicated the possibility of nonsurgical and conservative treatment, which is discussed in this review. This review explores the potential of nonsurgical approaches for curing anal fistulas through bacterial inhibition and immunomodulation. The longstanding cryptoglandular theory has been a subject of controversy, prompting the reevaluation of conventional surgical interventions for anal fistulas. The review was conducted through database searches, including Medline, EMBASE, PubMed, and the Cochrane Library. Emerging evidence suggests that targeting the anaerobic environments present in anal fistulas and perianal abscesses and eradicating bacteria and their by-products may be critical for successful treatment. Immunomodulatory strategies show promise as a potential avenue for the nonsurgical management of anal fistulas. Ongoing developments in pharmacological research offer opportunities for alternative treatment options, shedding light on the prospects of noninvasive anal fistula management.

Open article ↗



2024-10-21 | [Treatment of chronic sinus tract leakage at rectal anastomosis with anal fistula endoscopy].

Objective: To introduce the method of using anal fistula endoscope to treat chronic sinus tract leakage at rectal anastomosis site. Methods: We used anal fistula endoscopy to treat a patient with chronic sinus tract leakage after radical resection of rectal cancer, mainly including the following 5 steps: (1) establishing a water injection circulation system through the anus; (2) scraping off purulent coating and mucosa on the surface of the sinus tract with the brush; (3) hemostasis and removal of necrotic tissue with electrocoagulation rods; (4) filling the sinus tract with bioprotein gel; (5) compressing the sinus tract with transanal drainage tube. Results: The patient is a 70 year old male with rectal cancer. After undergoing 3D laparoscopic assisted radical resection of rectal cancer via abdominal anterior resection (Dixon's procedure) and diverting ileostomy surgery for more than 3 months, leakage of the rectal anastomosis was found through colonoscopy and anal iodine water contrast imaging .The patient started eating and flowing juice 6 hours after surgery, got out of bed 24 hours after surgery, and was discharged 48 hours after the removal of the anal canal. Three months after surgery, colonoscopy and transanal iodine hydrography showed that the sinus repair was intact. The diverting ileostomy was reduced 4 months after surgery. Conclusion: Anal fistula endoscope is safe and feasible for the treatment of chronic sinus tract anastomotic leakage in selected patients.

Open article ↗



2024-05-06 | Use of Anal Fistula Plug for Treatment of Fistula-in-ano: A Novel Technique?

Abstract Background: Fistula-in-ano is a chronic phase of anorectal suppuration characterized by purulent discharge. The conventional gold standard fistulotomy opens the entire track to heal with secondary intention. Anal fistula plug (AFP) is one of the newer modalities where the track is debrided from within and plugged with a biodegradable material made of porcine small intestinal submucosa. Materials and Methods: A total of 100 patients were enrolled in a randomized prospective study into two groups: conventional fistulotomy (CF) group and AFP group with 50 patients in each arm. The demography and surgical outcomes were assessed for postoperative pain, discharge and recovery, and failure. Results: All 100 patients included in the study had a history of anorectal suppuration which led to the residual anal fistula. Postoperative pain and analgesic requirements were equal in the two groups. The recovery period and return to work were shorter in the AFP group, and this difference was statistically significant. The success rate was 100% in the CF group as compared to 76% in the AFP group. There was no significant complication, failure, or recurrence in the CF group as against allergy (1), extrusion of plug (2), and failure/recurrence (9) in the AFP group. Conclusion: Our study shows that the application of bioprosthetic plugs may be an alternative option in a select group of patients. AFP has also shown to have a faster recovery with less morbidity and comparable success rates.

Open article ↗



2023-11-15 | Treatment Approaches for the Effective Management of Anal Fistula in the Modern Era

A complication of incision drainage or abscess ulceration around the anus and rectum is anal fistula which manifests as the creation of irregular channels linking the rectum and anal canal with the skin circumambient to the anus. It mostly affects the male population having a yearly frequency of two cases per ten thousand individuals. Histologically in anal fistula chronic inflammatory cells and fibrous tissues are surrounded by epithelialization of variable degree, which are categorized as squamous, columnar, or transitional zone epithelium. Anal fistula influences the psychological condition of the patients, which leads to depression or anxiety symptoms, in addition to severely impacting their standards of living. In general, anal fistula cannot be treated without medical intervention and the most efficient treatment for anal fistula is surgery. The optimal treatment in the modern era includes the elimination of the infected lesion, adequate drainage, and fistula closure while minimizing injury to the anal sphincter which includes treatment with fibrin glue, fistula plug, LIFT, etc.

Open article ↗



cell therapies
2026-09-14 | Novel and Experimental Therapies for Anal Fistula

Abstract Anal fistula is a challenging clinical entity primarily due to complex anatomy, the risk of recurrence, and the potential for incontinence resulting from treatment. Traditional surgical approaches, such as fistulotomy, seton placement, advancement flap, and ligation of the intersphincteric fistula tract, offer effective solutions for numerous cases but may carry the risk of sphincter damage or suboptimal healing in complex fistulas. As a result, multiple minimally invasive and biologics-based therapies have emerged, including video-assisted anal fistula treatment, laser fistula closure, endoscopic closure devices such as over-the-scope clips, next-generation biomaterial scaffolds, platelet-rich plasma, and mesenchymal stem cell therapy. Each of these approaches has distinct mechanisms, clinical evidence, and limitations. More recent innovations include next-generation biomaterials and the integration of artificial intelligence for optimized diagnostic and treatment planning. This chapter reviews the mechanisms, clinical trial evidence, outcomes, and future directions for these novel therapies in both cryptoglandular and Crohn's disease–associated anal fistulas, emphasizing clinical relevance and decision-making.

Open article ↗



2026-08-31 | Comparative effectiveness of sphincter-sparing and non-sphincter-sparing procedures for complex anal fistulas: A systematic review and network meta-analysis of postoperative incontinence, pain, and quality of life.

In complex anal fistulas, treatment should achieve healing while preserving continence and quality of life. However, direct comparative evidence across sphincter-preserving, sphincter-dividing/reconstructive, and seton-based approaches remains limited. We compared these techniques for postoperative fecal incontinence, pain, quality of life, and recurrence. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Network Meta-Analysis checklist to report our study. We searched PubMed, Embase, and CENTRAL until August 2025. We included randomized controlled trials and nonrandomized controlled trials in adults with complex cryptoglandular anal fistulas. We extracted data via Research Electronic Data Capture and performed risk-of-bias evaluation via Risk of Bias 2/ROBINS-I. We performed data analysis using MetaXL with setonas the reference technique. We used Grading of Recommendations Assessment, Development, and Evaluation to rate the certainty of our evidence. We included 2,972 patients across 43 studies. For fecal incontinence, adipose-derived stem cells plus fibrin glue and video-assisted anal fistula treatment combined with ligation of the intersphincteric fistula tract showed the most consistent reductions compared with seton (moderate-high certainty). For pain, the JUMP seton technique (described by Khoshnevis et al) and video-assisted anal fistula treatment combined with ligation of the intersphincteric fistula tract were associated with lower pain scores (moderate certainty). Soluble N-ethylmaleimide-sensitive factor attachment protein receptor, video-assisted anal fistula treatment combined with ligation of the intersphincteric fistula tract, and ligation of the intersphincteric fistula tract plus platelet-rich plasma showed higher quality-of-life scores compared with seton (moderate certainty). Recurrence was lower with adipose-derived stem cells plus fibrin glue (relative risk, 0.02) and acellular dermal matrix (relative risk, 0.08) compared with seton. Randomized controlled trial-only sensitivity analyses were consistent with low inconsistency. Ligation and adhesive-based approaches showed an advantage over seton-based techniques in terms of fecal incontinence, pain, and quality-of-life results with comparable recurrence rates. These results highlight the importance of careful patient selection and choosing specific surgical approaches to improve patients' outcomes.

Open article ↗



2026-07-11 | Autologous concentrated growth factors promote M2 macrophage polarization to accelerate wound healing after anal fistula surgery by activating the AKT/mTOR pathway.

Delayed healing of post-operative anal fistula wounds is driven by a hostile inflammatory microenvironment. While autologous concentrated growth factors (ACGF) show regenerative potential, the underlying immunomolecular mechanisms remain unclear. This study investigates if ACGF accelerates contaminated wound healing by modulating macrophage polarization via the AKT/mTOR pathway. In vitro, RAW264.7 macrophages were treated with ACGF to assess phenotypic switching and AKT/mTOR activation. The paracrine effects of ACGF-primed macrophages on fibroblasts were evaluated using a co-culture system with AKT-siRNA validation. In vivo, a rat fecal-contaminated wound model was established. Therapeutic efficacy, with or without the AKT inhibitor Triciribine, was assessed via laser speckle imaging, histology, and immunofluorescence. ACGF effectively reprogrammed macrophages from a pro-inflammatory M1 phenotype toward a reparative M2 phenotype, significantly upregulating CD206 and Arg-1 expression while activating AKT/mTOR signaling. Mechanistically, ACGF-primed macrophages significantly boosted RSF proliferation, migration, and collagen synthesis, effects that were substantially abrogated by AKT silencing. In vivo, ACGF treatment markedly accelerated wound closure, enhanced microvascular perfusion, and increased the density of CD31 + and Ki67 + cells. These regenerative benefits were accompanied by a significant shift toward M2 infiltration and a reduction in pro-inflammatory cytokines, all of which were reversed by pharmacological inhibition of AKT. ACGF promotes the healing of contaminated wounds by orchestrating an AKT/mTOR-dependent macrophage M2 polarization. This shift initiates a beneficial paracrine relay that enhances fibroblast activity and neoangiogenesis, effectively restoring the regenerative niche. Our findings establish ACGF as a potent immunomodulatory biomaterial and offer a promising therapeutic strategy for complex perianal wounds and chronic recalcitrant defects.

Open article ↗



2026-06-23 | Use of microfragmented autologous adipose tissue (LIPOGEMS®) as a sphincter-saving therapy for complex anal fistulas: a single-center retrospective study.

Complex anal fistulas remain a therapeutic challenge due to high recurrence rates and the risk of incontinence associated with conventional treatments. Microfragmented autologous adipose tissue has emerged as a sphincter-sparing option with potential regenerative and anti-inflammatory properties. This study aimed to evaluate the safety and efficacy of its injection into the fistula tract combined with closure of the internal opening. A single-center, retrospective, observational study was conducted between June 2019 and May 2025. All patients with complex anal fistulas treated with microfragmented adipose tissue processed with LIPOGEMS® system were included. Demographic data, fistula characteristics, surgical history, perioperative variables, postoperative morbidity, healing rate, and hospital stay were analyzed. Follow-up visits were performed weekly in the first month, and at 3, 6 and 12 months thereafter. A total of 28 patients with complex fistula were included. Mean patient age was 51.2 years (SD: 15.3), with predominance of males (69.7%). Most fistulas were medium or high transsphincteric (85.7%) and the main location was posterior (57.1%). 75% of patients had undergone previous curative-intent procedures. Median operative time was 71 minutes, and median processed adipose volume was 14 ml. Two postoperative complications were recorded (one abdominal hematoma-CD I and one perianal abscess-CD IIIa). After a median follow-up of 11.2 months, the overall healing rate was 46.4%, higher in primary (57.1%) and posterior fistulas (56.3%). Median hospital stay was one day, and median clinical closure occurred at 2.7 months. LIPOGEMS® therapy appeared safe, feasible, and associated with encouraging healing outcomes, offering advantages in functional preservation and recovery. Larger prospective studies are needed to confirm these results and refine its role in fistula management.

Open article ↗



2026-06-20 | Comparison of incision and drainage procedure with drainage and ligation of the intersphincteric fistula tract in the treatment of deep perianal abscess.

Patients with deep perianal abscess (DPA) and transsphincteric fistula typically require incision and drainage as emergency treatment. However, recurrent abscesses and fistulas are common. This study aimed to evaluate the impact of simultaneous ligation of the intersphincteric fistula tract (LIFT) on abscess recurrence, incontinence, and fistula healing. This study is a retrospective analysis of an institutional protocol and includes 111 patients divided into two groups: Group I (incision and drainage alone, n = 57) and Group II (incision and drainage combined with the LIFT procedure, n = 54). The primary endpoint was persistent fistula at 6 months, confirmed by clinical examination and magnetic resonance imaging (MRI). Secondary endpoints included abscess recurrence, Wexner incontinence score changes, and complications. Firth's penalized logistic regression, inverse probability of treatment weighting (IPTW), and log-rank analyses were performed to assess outcomes. At the 3rd month, the number of patients with persistent fistula was 16 (28.1%) in Group I, while it was 3 patients (5.6%) in Group II (P = 0.002). At the 6th month, persistent fistula was observed in 21 of 55 patients (38.2%) in Group I and 3 of 53 patients (5.7%) in Group II (P < 0.001). Firth's penalized logistic regression showed that the LIFT procedure was significantly associated with reduced fistula persistence (OR = 0.079, 95% CI 0.019-0.327, P < 0.001). A sensitivity analysis restricted to patients with MRI-confirmed transsphincteric fistula (Group I: n = 34; Group II: n = 54) confirmed these findings (59.4% vs. 5.7%, P < 0.001). IPTW-adjusted analysis yielded consistent results (weighted OR = 0.063). This study demonstrates that the LIFT procedure, when applied together with drainage, reduces the incidence of persistent fistula and shows a non-significant reduction in abscess recurrence in patients with DPA and complex anal fistula. These findings should be interpreted with caution due to the non-randomized design and require confirmation through prospective randomized controlled trials.

Open article ↗



small molecules
2026-07-19 | IFTAK (Interception of Fistulous Tract with Application of Ksharasutra) Technique: A Novel Approach in the Management Anal Fistula

Fistula in ano is a chronic suppurative condition of anorectal origin that frequently develops from cryptoglandular infection and is associated with persistent symptoms, recurrence, and the potential risk of sphincter damage. Although Kshara Sutra (medicated seton) therapy is a well-established Ayurvedic surgical procedure for its management, conventional practice is often limited by prolonged treatment duration, pain, and reduced patient compliance. The Interception of Fistulous Tract with Application of Kshara Sutra (IFTAK) technique has been developed to overcome these limitations by targeting the primary site of infection. A 51-year-old male patient presented with a two-and-a-half-year history of recurrent pus discharge from the perianal region accompanied by mild pain, itching, and difficulty in sitting. Clinical examination revealed a hypertrophied external opening at 2 o’clock position and an internal opening at the 6 o’clock position at the dentate line, with normal anal sphincter tone based on clinical assessment, a diagnosis of fistula-in-ano (Bhagandara) was made. The patient was treated using the IFTAK technique under local anesthesia. Weekly Kshara Sutra changing was performed, and curettage of the tract was undertaken when indicated. Progressive improvement was noted with a marked reduction in pain and purulent discharge. Complete resolution of discharge was achieved, followed by successful cut-through and full wound healing with minimal scarring. Anal continence was preserved, and no complications were observed. The patient remained symptom-free, with no recurrence during a one-year follow-up period. This case demonstrates that the IFTAK technique is an effective and safe modification of conventional Kshara (medicated seton) Sutra therapy for fistula in ano. By addressing the primary cryptoglandular source and reducing the length of the treated tract, IFTAK offers faster healing, improved patient comfort, and favorable clinical outcomes without recurrence.

Open article ↗



2026-06-29 | Cyanoacrylate Glue Insertion Versus Seton Placement in the Management of Trans-sphincteric Anal Fistula: A Prospective Comparative Study.

Anal fistula is a common perianal condition associated with significant morbidity, recurrence, and risk of incontinence. Traditional surgical techniques such as seton placement are effective but are often associated with pain, prolonged healing time, and extended hospitalisation. Cyanoacrylate glue has emerged as a minimally invasive sphincter-preserving alternative. This prospective comparative study was conducted at Sri Ramachandra Institute of Higher Education and Research, Chennai, India, between June 1, 2023, and December 31, 2024. Fifty patients with uncomplicated trans-sphincteric fistula (St James University Hospital classification grade 3) were randomly allocated to receive either seton placement (n=25) or cyanoacrylate glue insertion (n=25). Primary outcomes included postoperative pain measured by visual analogue scale (VAS), duration of hospital stay, healing time, healing rate, and anal incontinence assessed by the Wexner continence score. The mean age was 45.3 years (SD 8.2) in the seton group and 39.1 years (SD 7.6) in the glue group. Both groups were comparable in demographic characteristics. VAS pain scores were significantly lower in the glue group compared with the seton group (mean 2.0 (SD 0.8) vs 3.4 (SD 1.1); p<0.001). Hospital stay was shorter in the glue group (2.6 days (SD 1.2) vs 5.3 days (SD 1.8); p<0.001). Healing time was significantly reduced with cyanoacrylate glue (2.75 weeks (SD 1.1) vs 5.79 weeks (SD 2.3); p<0.001). Healing rates were 96% (24 of 25) in the seton group versus 80% (20 of 25) in the glue group (p=0.189). No anal incontinence was observed in either group at three-month follow-up. Cyanoacrylate glue insertion offers a safe, minimally invasive alternative to seton placement for carefully selected patients with uncomplicated trans-sphincteric anal fistula, with significant advantages in pain reduction, shorter hospital stay, and faster healing. Although healing rates were lower with glue (80% vs 96%), this difference was not statistically significant, and the study was underpowered to detect this difference in healing rate as a secondary endpoint. All treatment failures were successfully managed with salvage fistulotomy or repeat glue application without morbidity. Larger randomised controlled trials adequately powered for healing rate as a co-primary endpoint are warranted to confirm long-term efficacy.

Open article ↗



2026-06-16 | COMPREHENSIVE CLINICAL REVIEW: MODERN AND AYURVEDIC PERSPECTIVES ON ANAL FISTULA AND FISSURE-IN-ANO

Anorectal disorders, specifically fistula-in-ano (Bhagandara) and fissure-in-ano (Parikartika), represent a significant portion of colorectal clinical practice. A fistula-in-ano is characterized by an abnormal epithelialized tract connecting the perianal skin to the anal canal, often arising from chronic anorectal abscesses. In contrast, a fissure-in-ano is a longitudinal tear in the distal anal canal mucosa. This review article explores the etiology, pathophysiology, and diagnostic frameworks for these conditions. Special emphasis is placed on the comparative analysis of modern surgical interventions—such as fistulotomy, fistulectomy, and LIFT (Ligation of Intersphincteric Fistula Tract)—against traditional Ayurvedic parasurgical procedures, specifically Kshar Sutra therapy. The objective is to provide a holistic management protocol that minimizes recurrence and preserves sphincter function. The review concludes that while modern diagnostics (MRI) are essential for mapping, the integration of Ayurvedic herbal management and Kshar Sutra offers a viable, minimally invasive alternative with low recurrence rates for complex cases.

Open article ↗



2026-06-12 | Anterior Horseshoe Anal Fistula Treated With IFTAK (Interception of Fistulous Track With Application of Ksharasutra) Technique: A Case Study.

Anterior horseshoe anal fistula is a challenging variant of complex anorectal infections. Classical surgeries, including ksharasutra therapy in these cases may result in extensive postsurgical scarring and anal incontinence. On the other hand, interception of fistulous track with application of ksharasutra (IFTAK) technique has emerged as a novel way of managing anal fistulas because of its nature of minimal invasiveness, ability to cut and heal tissues with controlled fibrosis, and continence preservation. Here, we explain a detailed case study of a 40-year-old gentleman who presented with a recurrent anterior horseshoe fistula effectively managed with IFTAK. The digital rectal examination (DRE), proctoscopy, methylene blue test, and probing were done to delineate tracts and confirm the diagnosis. Fistula healed completely and showed no recurrence at 8 months of follow-up. Compared to traditional methods, the technique results in a shorter hospital stay and a shorter treatment duration.

Open article ↗



2026-05-08 | A case report of postoperative poor drainage of perianal abscess in an obese diabetic patient treated with comprehensive therapy.

Postoperative inadequate drainage of perianal abscess is prevalent in obese patients with diabetes, caused by obesity-related high tissue pressure and diabetes-induced impaired immunity/microcirculation. We report a 25-year-old obese male (BMI 37.9 kg/m2) with newly diagnosed type 2 diabetes who developed recurrent abscess on postoperative Day 3 after surgery for perianal abscess, anal fistula, and mixed hemorrhoids. He was treated with active catheter drainage, ceftriaxone-based targeted anti-infection (guided by Klebsiella pneumoniae culture), and metformin + liraglutide for glucose control. The patient fully recovered with normalized inflammatory markers and blood glucose, without recurrence or anal fistula formation at 1-year follow-up. This validates the efficacy of the comprehensive strategy for high-risk patients with long-term clinical outcomes.

Open article ↗



antibodies
2026-09-22 | The impact of malnutrition on clinical outcomes in patients with perianal fistulizing Crohn's disease undergoing seton placement: A retrospective study.

Perianal involvement occurs in up to 50% of patients with Crohn's disease (CD). Despite combined management, 10%-20% require fecal diversion or proctectomy. Nutritional status may influence prognosis, but its role in fistulizing perianal disease is unclear. This study examines the impact of malnutrition on clinical outcomes in patients with perianal fistulizing CD. A retrospective cohort study was conducted. Clinical data were collected from the health records of patients with perianal CD at two centers from January 2010 to December 2022. Nutritional screening followed Nutrition Risk Screening-2002. Patients with a score ≥3 were evaluated for malnutrition using the Global Leadership Initiative on Malnutrition (GLIM) criteria. The prevalence of malnutrition and its association with the risk of adverse clinical outcomes were analyzed. Of 64 patients, 17 (26.6%) had malnutrition. Malnourished patients had higher proctitis rates (100% vs. 78.7%, P = 0.038), lower serum albumin (3.47 vs. 3.97 g/dL, P = 0.002), and lower hemoglobin (10.9 vs. 12.5 g/dL, P = 0.003). They were younger at diagnosis (24.2 vs. 30 years, P = 0.046), had lower body mass indices (19.7 vs. 24.9 kg/m2, P < 0.001), higher Harvey-Bradshaw index (10 vs. 5, P < 0.001), and more corticosteroid use (29.4% vs. 4.3%, P = 0.012). Malnourished patients had lower fistula healing (17.6% vs. 44.7%, P = 0.048), more proctectomies (47.1% vs. 14.9%, P = 0.007), and were more likely to undergo abdominal surgery (70.6% vs. 38.3%, P = 0.022). In the prespecified parsimonious multivariable model, malnutrition was significantly associated with proctectomy (aOR 4.478; 95% CI: 1.227-16.343; P = 0.023). Malnutrition is a significant clinical risk marker associated with the requirement for proctectomy in patients with perianal fistulizing CD who undergo seton placement.

Open article ↗



2026-09-02 | Comparison of Ligation of Intersphincteric Fistula Tract and Conventional Fistulectomy in the Management of Perianal Fistula.

Background Perianal fistula is a chronic anorectal disorder characterized by an epithelialized tract extending between the anal canal and the perianal skin, most frequently developing after cryptoglandular abscess formation. Patients commonly experience persistent discharge, pain, recurrent infections, and impaired quality of life. Although conventional fistulectomy remains an established treatment option, it may result in greater postoperative discomfort, slower wound healing, and potential impairment of continence. The ligation of intersphincteric fistula tract (LIFT) technique has gained acceptance as a sphincter-preserving procedure intended to minimize these complications while maintaining satisfactory treatment outcomes. Aim This study aimed to compare the clinical outcomes of the sphincter-preserving LIFT procedure with conventional fistulectomy in patients with perianal fistula by evaluating postoperative pain, wound infection, wound healing, postoperative fecal incontinence, and recurrence. Methods This prospective, randomized controlled trial was conducted in the Department of General Surgery at a tertiary care institution. Thirty patients with perianal fistula were randomly allocated in a 1:1 ratio to undergo either the LIFT procedure (n = 15) or conventional fistulectomy (n = 15). Outcomes assessed during follow-up included postoperative pain, wound infection, wound healing, postoperative fecal incontinence, and recurrence. Continuous variables were compared using the Mann-Whitney U test, while categorical variables were analysed using Fisher's exact test. Statistical significance was defined as a two-sided p value <0.05. Results Compared with conventional fistulectomy, the LIFT procedure was associated with significantly lower postoperative pain scores (median Visual Analogue Scale score: 2 vs. 5; Mann-Whitney U test, p < 0.001), lower rates of postoperative wound infection (6.7% vs. 46.7%; Fisher's exact test, p = 0.035), and improved postoperative wound healing (93.3% vs. 53.3%; Fisher's exact test, p = 0.035). Although postoperative recurrence (6.7% vs. 26.7%) and fecal incontinence (0.0% vs. 6.7%) occurred less frequently following the LIFT procedure, these differences were not statistically significant. Conclusion The LIFT procedure was associated with lower postoperative pain, fewer wound infections, and improved wound healing compared with conventional fistulectomy. Although lower rates of postoperative recurrence and fecal incontinence were observed following LIFT, these differences were not statistically significant. Larger multicenter studies with longer follow-up are required to confirm these findings.

Open article ↗



2026-06-30 | Association between intestinal functional disorders and anal fistula: evidence from a retrospective case-control study.

Clinical observations indicate that some individuals experience bowel dysfunction, such as diarrhea or constipation, prior to the diagnosis of anal fistula (AF). These observations suggest a potential association between pre-existing intestinal dysfunction and the occurrence of AF. However, systematic clinical evidence remains limited. This study aimed to evaluate the association between pre-diagnostic bowel dysfunction and AF and to explore whether such associations differ across AF anatomical subtypes. We conducted a retrospective hospital-based case-control study including 251 patients with newly diagnosed AF between July 2024 and July 2025. During the same period, 251 age- and sex-matched individuals without AF were selected as controls (1:1 matching; age ± 3 years). Demographic characteristics, lifestyle factors, and bowel function within 1 year before the index date were collected from medical records and supplementary interviews where applicable. Conditional logistic regression, accounting for the matched-pair design, was used to assess the association between bowel dysfunction and AF. Both crude (unadjusted) and adjusted analyses were performed. Stratified analyses were performed to explore heterogeneity across AF subtypes. Pre-existing bowel dysfunction was associated with a higher likelihood of developing AF (p < 0.05). Diarrhea showed a significant association with AF (OR ≈ 2.2), whereas constipation was not significantly associated. Smoking, alcohol consumption, prolonged sedentary or standing occupations, and higher body mass index (BMI) were also associated with AF. In exploratory analyses of AF subtypes, diarrhea showed modest heterogeneity across anatomical classifications, whereas constipation showed no significant variation across subtypes. This retrospective case-control study indicates that pre-existing intestinal functional disorders, particularly chronic diarrhea, are associated with a higher likelihood of AF, with the association appearing more pronounced among low anal fistulas. No consistent subtype-specific pattern was observed overall, although diarrhea showed modest heterogeneity across anatomical classifications in exploratory analyses. Given the retrospective observational design, these findings support association rather than causation and warrant confirmation in multicenter prospective studies. Clinically, these results suggest that earlier identification and risk assessment of patients with chronic diarrhea and other intestinal functional disturbances may provide valuable insights, but further research is needed to confirm these findings.

Open article ↗



2026-05-05 | Characteristics of Anal Fistula Cancer in Patients Who Underwent Surgery: A Nationwide Observational Study Using Diagnosis Procedure Combination Data

ABSTRACT Aim Anal fistula cancer is a rare disease that occurs in < 1% of patients with anal fistulas. The clinical characteristics of anal fistula cancer are not fully understood. This study aimed to identify the characteristics of patients with anal fistula cancer by comparing them with those of patients with anal canal or rectal cancer. Methods This was a nationwide observational study using the Diagnosis Procedure Combination data. Patients who underwent abdominoperineal resection or total pelvic exenteration for anal fistula, anal canal, or rectal cancer were included in this study. Patient background, surgical outcomes, postoperative complications, and medical costs were compared among the three types of cancer. Results This study included 206 patients with anal fistula cancer, 1207 patients with anal canal cancer, and 18 254 patients with rectal cancer. Patients with anal fistula cancer were more likely to be male, younger, or smokers. In patients with anal fistula cancer, the proportion of open surgeries was significantly higher, and the length of hospital stay was significantly longer than in those with anal canal and rectal cancer. Anal fistula cancer tended to be more locally advanced than other cancers, whereas lymph node and distant metastases were less common. The incidence of incisional wound infection and wound dehiscence was significantly higher, and medical costs were the highest in patients with anal fistula cancer. Conclusion Anal fistula cancer is characterized by aggressive local progression, resulting in a higher frequency of open surgery, a higher incidence of wound‐related complications, and higher medical costs.

Open article ↗



2025-12-30 | Anatomical Reappraisal of the Intersphincteric Space: A Histology-Based Reinterpretation of the Parks Classification of Anal Fistulas

Background: Anal fistula pathways have been traditionally described using the Parks classification; however, the microscopic nature of the “intersphincteric” space has never been characterized completely. Furthermore, the longitudinal muscle between the internal and external anal sphincters has a more complex structure than traditionally assumed. Objective: To clarify the layer-specific microanatomy of the anal sphincter region and reassess how the fistula pathways described by the Parks classification correspond to actual histological structures. Design: Descriptive histological analysis of cadaveric specimens. Settings: Department of Clinical Anatomy at Institute of Science Tokyo. Patients: Eleven adult, human donors who had consented to whole-body donation. Interventions: Tissue blocks containing the lateral anal canal were collected and processed for histological and immunohistochemical analyses in the transverse and coronal planes. Main Outcome Measures: Identification of the sphincter muscles, longitudinal muscles, levator ani muscles, interbundle gaps, and connective tissue compartments as well as their spatial relationships. Results: The longitudinal muscles exhibited a mosaic structure with dense and loose regions. The dense region ended near the mid-height of the internal sphincter, whereas the loose region expanded inferiorly to form a wide compartment of sparse fibers and loose connective tissue. From this compartment, the loose fibers branched laterally and inferiorly, passing through natural gaps within the external sphincter muscle. Two overlapping layers of the levator ani muscle were also identified. The loose compartment beneath the longitudinal muscle corresponded to the site identified by Parks classification as the origin of abscess formation. Limitations: Specimens were obtained from formalin-fixed cadavers of elderly donors, only the lateral anal canal wall was assessed, and correlations with clinical fistulas were inferential. Conclusions: The region between the sphincter muscles is not a simple plane, and instead, a heterogeneous compartment; its structural features provide a basis for the initiation and propagation patterns described in the Parks classification of anal fistulas.

Open article ↗



proteins
2025-07-09 | Single-cell RNA sequencing reveals the therapeutic mechanism of Calvatia lilacina in promoting wound healing of anal fistula

Background: Anal fistula is one of the most common and frequently occurring diseases in the anorectal department. Calvatia lilacina spore (CLS) has been applied for wound treatment with a long history as a traditional Chinese medicine (TCM). However, the mechanism of CLS to treat postoperative wound of anal fistula remains unclear. The present study aims to investigate the efficacy and mechanism of CLS in promoting anal fistula wound healing from the perspective of regulating the interaction between macrophages and fibroblasts. Methods: Twenty patients who received anal surgery were recruited in Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine. We presented a single-cell atlas of granulation tissue, comparing samples with and without CLS treatment, utilizing single-cell RNA sequencing. The pharmacological effects and mechanism of CLS on anal fistula wound were assessed using elisa, IHC staining, western blot, IF staining, flow cytometry assays and cell co-culture. Results: The CLS had a uniform particle size and contained components mainly including proteins, steroids, polysaccharides and polyphenols. CLS reduced the expression level of TNF-α and increased the expression levels of VEGF, Collagen I in the granulation tissue. The single-cell sequencing revealed that the expression level of IL-6 and CXCL-8 was increased in the IL-6+ macrophages that promoted the expression of WASF3 in fibroblasts and further recruited ACTR2, ACTR3. Finally, CLS increased intercellular communication between macrophages and fibroblasts, enhancing MSF migration ability by activating JAK2/STAT3 signaling pathway. Conclusion: Our study objectively demonstrated the pharmacological effects of CLS in promoting the wound healing of anal fistula and investigated its mechanisms in terms of regulating the immune inflammatory process of macrophages increases signal communication with fibroblasts while promoting fibroblast transformation.

Open article ↗



2025-01-15 | Curing cryptoglandular anal fistulas-Is it possible without surgery?

Empirical reviews suggested that cryptoglandular anal fistulas require surgical resolution. However, some reports have indicated the possibility of nonsurgical and conservative treatment, which is discussed in this review. This review explores the potential of nonsurgical approaches for curing anal fistulas through bacterial inhibition and immunomodulation. The longstanding cryptoglandular theory has been a subject of controversy, prompting the reevaluation of conventional surgical interventions for anal fistulas. The review was conducted through database searches, including Medline, EMBASE, PubMed, and the Cochrane Library. Emerging evidence suggests that targeting the anaerobic environments present in anal fistulas and perianal abscesses and eradicating bacteria and their by-products may be critical for successful treatment. Immunomodulatory strategies show promise as a potential avenue for the nonsurgical management of anal fistulas. Ongoing developments in pharmacological research offer opportunities for alternative treatment options, shedding light on the prospects of noninvasive anal fistula management.

Open article ↗



2024-10-21 | [Treatment of chronic sinus tract leakage at rectal anastomosis with anal fistula endoscopy].

Objective: To introduce the method of using anal fistula endoscope to treat chronic sinus tract leakage at rectal anastomosis site. Methods: We used anal fistula endoscopy to treat a patient with chronic sinus tract leakage after radical resection of rectal cancer, mainly including the following 5 steps: (1) establishing a water injection circulation system through the anus; (2) scraping off purulent coating and mucosa on the surface of the sinus tract with the brush; (3) hemostasis and removal of necrotic tissue with electrocoagulation rods; (4) filling the sinus tract with bioprotein gel; (5) compressing the sinus tract with transanal drainage tube. Results: The patient is a 70 year old male with rectal cancer. After undergoing 3D laparoscopic assisted radical resection of rectal cancer via abdominal anterior resection (Dixon's procedure) and diverting ileostomy surgery for more than 3 months, leakage of the rectal anastomosis was found through colonoscopy and anal iodine water contrast imaging .The patient started eating and flowing juice 6 hours after surgery, got out of bed 24 hours after surgery, and was discharged 48 hours after the removal of the anal canal. Three months after surgery, colonoscopy and transanal iodine hydrography showed that the sinus repair was intact. The diverting ileostomy was reduced 4 months after surgery. Conclusion: Anal fistula endoscope is safe and feasible for the treatment of chronic sinus tract anastomotic leakage in selected patients.

Open article ↗



2024-05-06 | Use of Anal Fistula Plug for Treatment of Fistula-in-ano: A Novel Technique?

Abstract Background: Fistula-in-ano is a chronic phase of anorectal suppuration characterized by purulent discharge. The conventional gold standard fistulotomy opens the entire track to heal with secondary intention. Anal fistula plug (AFP) is one of the newer modalities where the track is debrided from within and plugged with a biodegradable material made of porcine small intestinal submucosa. Materials and Methods: A total of 100 patients were enrolled in a randomized prospective study into two groups: conventional fistulotomy (CF) group and AFP group with 50 patients in each arm. The demography and surgical outcomes were assessed for postoperative pain, discharge and recovery, and failure. Results: All 100 patients included in the study had a history of anorectal suppuration which led to the residual anal fistula. Postoperative pain and analgesic requirements were equal in the two groups. The recovery period and return to work were shorter in the AFP group, and this difference was statistically significant. The success rate was 100% in the CF group as compared to 76% in the AFP group. There was no significant complication, failure, or recurrence in the CF group as against allergy (1), extrusion of plug (2), and failure/recurrence (9) in the AFP group. Conclusion: Our study shows that the application of bioprosthetic plugs may be an alternative option in a select group of patients. AFP has also shown to have a faster recovery with less morbidity and comparable success rates.

Open article ↗



2023-11-15 | Treatment Approaches for the Effective Management of Anal Fistula in the Modern Era

A complication of incision drainage or abscess ulceration around the anus and rectum is anal fistula which manifests as the creation of irregular channels linking the rectum and anal canal with the skin circumambient to the anus. It mostly affects the male population having a yearly frequency of two cases per ten thousand individuals. Histologically in anal fistula chronic inflammatory cells and fibrous tissues are surrounded by epithelialization of variable degree, which are categorized as squamous, columnar, or transitional zone epithelium. Anal fistula influences the psychological condition of the patients, which leads to depression or anxiety symptoms, in addition to severely impacting their standards of living. In general, anal fistula cannot be treated without medical intervention and the most efficient treatment for anal fistula is surgery. The optimal treatment in the modern era includes the elimination of the infected lesion, adequate drainage, and fistula closure while minimizing injury to the anal sphincter which includes treatment with fibrin glue, fistula plug, LIFT, etc.

Open article ↗



cell therapies
2026-09-14 | Novel and Experimental Therapies for Anal Fistula

Abstract Anal fistula is a challenging clinical entity primarily due to complex anatomy, the risk of recurrence, and the potential for incontinence resulting from treatment. Traditional surgical approaches, such as fistulotomy, seton placement, advancement flap, and ligation of the intersphincteric fistula tract, offer effective solutions for numerous cases but may carry the risk of sphincter damage or suboptimal healing in complex fistulas. As a result, multiple minimally invasive and biologics-based therapies have emerged, including video-assisted anal fistula treatment, laser fistula closure, endoscopic closure devices such as over-the-scope clips, next-generation biomaterial scaffolds, platelet-rich plasma, and mesenchymal stem cell therapy. Each of these approaches has distinct mechanisms, clinical evidence, and limitations. More recent innovations include next-generation biomaterials and the integration of artificial intelligence for optimized diagnostic and treatment planning. This chapter reviews the mechanisms, clinical trial evidence, outcomes, and future directions for these novel therapies in both cryptoglandular and Crohn's disease–associated anal fistulas, emphasizing clinical relevance and decision-making.

Open article ↗



2026-08-31 | Comparative effectiveness of sphincter-sparing and non-sphincter-sparing procedures for complex anal fistulas: A systematic review and network meta-analysis of postoperative incontinence, pain, and quality of life.

In complex anal fistulas, treatment should achieve healing while preserving continence and quality of life. However, direct comparative evidence across sphincter-preserving, sphincter-dividing/reconstructive, and seton-based approaches remains limited. We compared these techniques for postoperative fecal incontinence, pain, quality of life, and recurrence. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Network Meta-Analysis checklist to report our study. We searched PubMed, Embase, and CENTRAL until August 2025. We included randomized controlled trials and nonrandomized controlled trials in adults with complex cryptoglandular anal fistulas. We extracted data via Research Electronic Data Capture and performed risk-of-bias evaluation via Risk of Bias 2/ROBINS-I. We performed data analysis using MetaXL with setonas the reference technique. We used Grading of Recommendations Assessment, Development, and Evaluation to rate the certainty of our evidence. We included 2,972 patients across 43 studies. For fecal incontinence, adipose-derived stem cells plus fibrin glue and video-assisted anal fistula treatment combined with ligation of the intersphincteric fistula tract showed the most consistent reductions compared with seton (moderate-high certainty). For pain, the JUMP seton technique (described by Khoshnevis et al) and video-assisted anal fistula treatment combined with ligation of the intersphincteric fistula tract were associated with lower pain scores (moderate certainty). Soluble N-ethylmaleimide-sensitive factor attachment protein receptor, video-assisted anal fistula treatment combined with ligation of the intersphincteric fistula tract, and ligation of the intersphincteric fistula tract plus platelet-rich plasma showed higher quality-of-life scores compared with seton (moderate certainty). Recurrence was lower with adipose-derived stem cells plus fibrin glue (relative risk, 0.02) and acellular dermal matrix (relative risk, 0.08) compared with seton. Randomized controlled trial-only sensitivity analyses were consistent with low inconsistency. Ligation and adhesive-based approaches showed an advantage over seton-based techniques in terms of fecal incontinence, pain, and quality-of-life results with comparable recurrence rates. These results highlight the importance of careful patient selection and choosing specific surgical approaches to improve patients' outcomes.

Open article ↗



2026-07-11 | Autologous concentrated growth factors promote M2 macrophage polarization to accelerate wound healing after anal fistula surgery by activating the AKT/mTOR pathway.

Delayed healing of post-operative anal fistula wounds is driven by a hostile inflammatory microenvironment. While autologous concentrated growth factors (ACGF) show regenerative potential, the underlying immunomolecular mechanisms remain unclear. This study investigates if ACGF accelerates contaminated wound healing by modulating macrophage polarization via the AKT/mTOR pathway. In vitro, RAW264.7 macrophages were treated with ACGF to assess phenotypic switching and AKT/mTOR activation. The paracrine effects of ACGF-primed macrophages on fibroblasts were evaluated using a co-culture system with AKT-siRNA validation. In vivo, a rat fecal-contaminated wound model was established. Therapeutic efficacy, with or without the AKT inhibitor Triciribine, was assessed via laser speckle imaging, histology, and immunofluorescence. ACGF effectively reprogrammed macrophages from a pro-inflammatory M1 phenotype toward a reparative M2 phenotype, significantly upregulating CD206 and Arg-1 expression while activating AKT/mTOR signaling. Mechanistically, ACGF-primed macrophages significantly boosted RSF proliferation, migration, and collagen synthesis, effects that were substantially abrogated by AKT silencing. In vivo, ACGF treatment markedly accelerated wound closure, enhanced microvascular perfusion, and increased the density of CD31 + and Ki67 + cells. These regenerative benefits were accompanied by a significant shift toward M2 infiltration and a reduction in pro-inflammatory cytokines, all of which were reversed by pharmacological inhibition of AKT. ACGF promotes the healing of contaminated wounds by orchestrating an AKT/mTOR-dependent macrophage M2 polarization. This shift initiates a beneficial paracrine relay that enhances fibroblast activity and neoangiogenesis, effectively restoring the regenerative niche. Our findings establish ACGF as a potent immunomodulatory biomaterial and offer a promising therapeutic strategy for complex perianal wounds and chronic recalcitrant defects.

Open article ↗



2026-06-23 | Use of microfragmented autologous adipose tissue (LIPOGEMS®) as a sphincter-saving therapy for complex anal fistulas: a single-center retrospective study.

Complex anal fistulas remain a therapeutic challenge due to high recurrence rates and the risk of incontinence associated with conventional treatments. Microfragmented autologous adipose tissue has emerged as a sphincter-sparing option with potential regenerative and anti-inflammatory properties. This study aimed to evaluate the safety and efficacy of its injection into the fistula tract combined with closure of the internal opening. A single-center, retrospective, observational study was conducted between June 2019 and May 2025. All patients with complex anal fistulas treated with microfragmented adipose tissue processed with LIPOGEMS® system were included. Demographic data, fistula characteristics, surgical history, perioperative variables, postoperative morbidity, healing rate, and hospital stay were analyzed. Follow-up visits were performed weekly in the first month, and at 3, 6 and 12 months thereafter. A total of 28 patients with complex fistula were included. Mean patient age was 51.2 years (SD: 15.3), with predominance of males (69.7%). Most fistulas were medium or high transsphincteric (85.7%) and the main location was posterior (57.1%). 75% of patients had undergone previous curative-intent procedures. Median operative time was 71 minutes, and median processed adipose volume was 14 ml. Two postoperative complications were recorded (one abdominal hematoma-CD I and one perianal abscess-CD IIIa). After a median follow-up of 11.2 months, the overall healing rate was 46.4%, higher in primary (57.1%) and posterior fistulas (56.3%). Median hospital stay was one day, and median clinical closure occurred at 2.7 months. LIPOGEMS® therapy appeared safe, feasible, and associated with encouraging healing outcomes, offering advantages in functional preservation and recovery. Larger prospective studies are needed to confirm these results and refine its role in fistula management.

Open article ↗



2026-06-20 | Comparison of incision and drainage procedure with drainage and ligation of the intersphincteric fistula tract in the treatment of deep perianal abscess.

Patients with deep perianal abscess (DPA) and transsphincteric fistula typically require incision and drainage as emergency treatment. However, recurrent abscesses and fistulas are common. This study aimed to evaluate the impact of simultaneous ligation of the intersphincteric fistula tract (LIFT) on abscess recurrence, incontinence, and fistula healing. This study is a retrospective analysis of an institutional protocol and includes 111 patients divided into two groups: Group I (incision and drainage alone, n = 57) and Group II (incision and drainage combined with the LIFT procedure, n = 54). The primary endpoint was persistent fistula at 6 months, confirmed by clinical examination and magnetic resonance imaging (MRI). Secondary endpoints included abscess recurrence, Wexner incontinence score changes, and complications. Firth's penalized logistic regression, inverse probability of treatment weighting (IPTW), and log-rank analyses were performed to assess outcomes. At the 3rd month, the number of patients with persistent fistula was 16 (28.1%) in Group I, while it was 3 patients (5.6%) in Group II (P = 0.002). At the 6th month, persistent fistula was observed in 21 of 55 patients (38.2%) in Group I and 3 of 53 patients (5.7%) in Group II (P < 0.001). Firth's penalized logistic regression showed that the LIFT procedure was significantly associated with reduced fistula persistence (OR = 0.079, 95% CI 0.019-0.327, P < 0.001). A sensitivity analysis restricted to patients with MRI-confirmed transsphincteric fistula (Group I: n = 34; Group II: n = 54) confirmed these findings (59.4% vs. 5.7%, P < 0.001). IPTW-adjusted analysis yielded consistent results (weighted OR = 0.063). This study demonstrates that the LIFT procedure, when applied together with drainage, reduces the incidence of persistent fistula and shows a non-significant reduction in abscess recurrence in patients with DPA and complex anal fistula. These findings should be interpreted with caution due to the non-randomized design and require confirmation through prospective randomized controlled trials.

Open article ↗



Access all drug discovery papers and probability of success in trials forecasts:

Access all drug discovery papers and probability of success in trials forecasts:

Drug Discovery Landscape

4 orphan drug designations for Anal fistula, including 1 approved therapy.

4 orphan drug designations for Anal fistula, including 1 approved therapy.

Drug

Therapy type

Orphan designation

Clinical trial status

Sponsor

darvadstrocel

cell therapies

FDA
2022-02-22

Phase I/II
Terminated

Takeda Development Center Americas, Inc.

expanded human allogeneic mesenchymal adult stem cells extracted from adipose tissue

cell therapies

FDA
2017-10-18

Phase III
Completed

Takeda Development Center Americas, Inc.

Darvadstrocel [Alofisel]

cell therapies

EMA
2009-10-08

Approved
2018-03-27

Takeda Pharma A/S

Autologous adipose-derived mesenchymal stem cells expanded [Ontaril]

cell therapies

EMA
2005-08-26

Phase III
Terminated

Tigenix S.A.

“Terminated” – programs with discontinued clinical trials, or with no updates reported for 5 years after completion or 12 years after the last trial started.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.